Skip to main content
Clinical Trials/NCT01504893
NCT01504893
Completed
Not Applicable

Multicenter Randomized Trial on Protective Ventilation Versus Conventional Ventilation During OLV in Patients Undergoing Thoracic Surgery

Azienda Ospedaliera S. Maria della Misericordia16 sites in 1 country984 target enrollmentSeptember 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Respiratory Distress Syndrome
Sponsor
Azienda Ospedaliera S. Maria della Misericordia
Enrollment
984
Locations
16
Primary Endpoint
Acute Respiratory Distress Syndrome (ARDS) incidence
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to determine if a protective ventilatory strategy during one-lung ventilation (OLV) based on low tidal volume, PEEP and alveolar recruitment maneuver can reduce Acute Respiratory Distress Syndrome (ARDS) and Postoperative pulmonary complications (PPCs) after major pulmonary resection.

Primary endpoint: Evaluation of postoperative ARDS incidence

Secondary endpoint: Evaluation od PPC incidence and postoperative outcomes (other complications, unplanned Intensive Care Admission, hospital and ICU length of stay, in-hospital mortality)

Detailed Description

Pulmonary postoperative complications (PPCs) are the most frequent adverse events after thoracic surgery. Acute respiratory distress syndrome (ARDS) is the most severe among PPCs. Injurious mechanical ventilation is a recognized risk factor associated with ARDS and PPCs after major thoracic surgery. International literature reports a wide use of tidal volume around 5-6 ml/kg predicted body weight (PBW) during one lung ventilation (OLV) but variable use of PEEP and alveolar recruitment maneuver (ARM). The aim of this multicenter, randomized, single blind study is to determine if a protective ventilatory strategy during OLV based on low tidal volume, PEEP and alveolar recruitment maneuver compared to conventional strategy can reduce ARDS and PPCs after major pulmonary resection. Primary outcome is the incidence of in-hospital ARDS. Secondary outcomes are in-hospital incidence of postoperative pulmonary complications (PPCs), major cardiovascular events, unplanned Intensive Care Unit admission, in-hospital length of stay and mortality RANDOMIZATION Patients are randomly assigned to receive protective or conventional OLV according to a computer-generated randomization list (1:1 ratio) before anesthesia induction. Patients are blinded to the treatment. Anesthesiologists and surgeons are unblinded to the treatment during the surgical procedure and the postoperative outcome assessment. MEASUREMENTS Intraoperative collection of ventilatory settings, airway pressures, arterial blood gases analysis at the following time points: T1: two lung ventilation in supine position before placing the patient in lateral decubitus; T2: 30 minutes after OLV start; T3: 60 minutes after OLV start; T4: 20 minutes after lobectomy/pneumonectomy (during OLV); T5: 15 minutes after ARM in supine position and during two lung ventilation. Postoperative data collection 1, 12, 24, 36, 48 hours after surgery and at discharge. Arterial blood gas analysis will be performed 1 hour after extubation and 24 and 72 hours after surgery (or in case of respiratory insufficiency).

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
September 2017
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Azienda Ospedaliera S. Maria della Misericordia
Responsible Party
Principal Investigator
Principal Investigator

Giorgio Della Rocca

M.D.

Azienda Ospedaliera S. Maria della Misericordia

Eligibility Criteria

Inclusion Criteria

  • Patients ≥ 18 years
  • Elective thoracotomies or thoracoscopic major lung resection surgery (lobectomy, bilobectomy, pneumonectomy)

Exclusion Criteria

  • Emergency surgery
  • Wedge resection or atypical resection
  • Non-resective lung surgery requiring OLV
  • Patients \< 18 years
  • BMI \< 20 and BMI \> 29
  • Heart disease with ejection fraction \<50% and/or severe valvulopathy
  • Pulmonary hypertension
  • Renal failure requiring dialytic treatment
  • Drug addiction
  • Mental retardation, depression and psychiatric disease

Outcomes

Primary Outcomes

Acute Respiratory Distress Syndrome (ARDS) incidence

Time Frame: Hospital stay (7 days average expected)

incidence of ARDS (%)

Secondary Outcomes

  • Postoperative pulmonary complications (PPCs)(Hospital stay (7 days average expected))
  • In-hospital mortality(Hospital stay (7 days average aspected))
  • Postoperative complications(Hospital stay (7 days average expected))
  • Unplanned Intensive Care Unit (ICU) admission(Hospital stay (7 days average aspected))
  • Intensive Care Unit (ICU) Length of stay(Hospital stay (7 days average aspected))
  • Length of hospital stay(Hospital stay (7 days average expected))

Study Sites (16)

Loading locations...

Similar Trials